Navigation Links
Promise of Vical's CMV Vaccine Noted by Independent Experts
Date:6/5/2008

l drug use and viral load in patients receiving vaccine compared with patients receiving placebo. Other important evaluations will include measurement of specific immune responses against CMV targeted by the vaccine.

"We are advancing well toward completion of enrollment in our Phase 2 CMV vaccine trial," said Ronald B. Moss, M.D., Vice President of Clinical Development at Vical, "and are on track for our planned interim evaluation of safety and efficacy data in the second half of 2008. Our immunotherapeutic vaccine may help address the serious healthcare problem of CMV reactivation for transplant patients, and could eventually be useful in preventing birth defects caused by CMV infection of pregnant women."

About CMV

CMV is a herpes virus that infects more than half of all adults in the United States by age 40, and is even more widespread in developing countries. While a healthy immune system typically protects an infected person against CMV disease, it rarely succeeds in completely eliminating the infection, and those whose immune systems are not fully functional are at high risk of CMV proliferation, potentially leading to severe illness or death. These include transplant patients who take immunosuppressive drugs, and fetuses and newborns of mothers who first become infected during pregnancy.

CMV infection affects 30 to 60 percent of the patients undergoing various transplant procedures, causing transplant rejection, serious illness and even death if untreated. Expensive antiviral drug therapy is used to control the disease, but does not eliminate the infection. Congenital CMV infection affects one out of every hundred infants, and causes severe consequences in about 3,600 infants and death in about 400 each year in the United States.

There is no approved vaccine against CMV. Vaccine approaches that result in predominantly antibody responses to CMV have not proven highly effective in transplant patients. Vaccine approaches using
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
2. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
3. Newly Approved HIV Drug Shows Great Promise
4. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
5. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
6. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
7. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
8. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
9. Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
10. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
11. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... market studies the current and future prospects of ... of patient,s health and assists medical practitioners in ... the disease progression during treatment. Multi-parameter patient monitoring ... and chronic disease. Geriatric population is observed to ...
(Date:9/2/2015)... 2, 2015 The quantum dot market report analyzes ... market based on the product includes medical devices, display, and ... lighting, battery and energy storage, QD laser, and transistor. The ... the quantum dot market. The report also provides the geographic ... , Europe , Asia-Pacific ...
(Date:9/2/2015)... , Sept. 2, 2015 Advanced ... Summary Advanced dressings have steadily replaced ... of a variety of wound indications, such as ... management, infection control, and physical protection become increasingly ... greater role in standard therapy. This report ...
Breaking Medicine Technology:Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Multi-parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2
(Date:9/3/2015)... ... September 03, 2015 , ... Hunters Creek Retrievers is ... a champion AKC Black Lab Puppy. Celebrate Fall 2015 with unlimited Free Hugs and ... family to enjoy Thanksgiving and Christmas with an extra big smile. , This ...
(Date:9/3/2015)... ... September 03, 2015 , ... AvePoint, the established leader in ... Pack (SP) 4 – AvePoint’s solution for facilitating two-way collaboration and external sharing ... Trend-Setting Product”. This is the fifth consecutive year an AvePoint product has made ...
(Date:9/3/2015)... WI (PRWEB) , ... September 03, 2015 , ... At ... after becoming dissatisfied with the traditional health care model, where the primary care physician ... of individuals who want to become educated about their health issues and empowered to ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... that Bob Anders and Kelley Chapman will be joining the company’s executive leadership ... , Anders has over 30 years’ experience in healthcare product and project management. ...
(Date:9/2/2015)... ... 2015 , ... Leah Binder, MA, MGA, president and CEO ... healthcare, will offer the keynote address at the upcoming meeting of the ACO ... Harbor, Florida, at the Innisbrook Resort and Golf Club. For an agenda and ...
Breaking Medicine News(10 mins):Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3
... found collapsed on a roadside and rushed to the University of ... and muscle breakdown, doctors were surprised to discover that a trendy ... ills. The URMC team reported the case study, believed to ... the American Journal of Emergency Medicine . They ...
... FL (For immediate release) -- Cotinine, a compound derived from ... in a mouse model of Alzheimer,s disease, a study led ... University of South Florida found. The findings are ... in advance of print publication. "We found a compound ...
... memantine submitted a supplementary analysis of study data, the German ... proof of a benefit of the drug for cognitive function, ... daily living, at least for a treatment period of 6 ... assessment of 2009. IQWiG had repeatedly called upon the manufacturer ...
... Mass. Colonoscopy is regarded as the most ... the potentially life-saving procedure can also be painful. ... of screening to reduce patient discomfort while also ... Tufts University,s School of Engineering led by Associate ...
... from the Sheikh Zayed Institute for Pediatric Surgical Innovation ... a drug that has shown early promise as an option ... to fight off bacterial infections, particularly sepsis. The ... journal Anesthesiology , sheds new light on the role ...
... New York, NY, April 27, 2011Ninety percent of American ... able to afford health insurance under the Affordable Care ... Jonathan Gruber and Ian Perry of the Massachusetts Institute ... available through health insurance exchanges established under the law ...
Cached Medicine News:Health News:Medical sleuthing linked muscle, kidney problems to kava tea 2Health News:Medical sleuthing linked muscle, kidney problems to kava tea 3Health News:Tobacco-derived compound prevents memory loss in Alzheimer's disease mice 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 2Health News:Long struggle for appropriately processed manufacturer data leads to a new assessment of memantine 3Health News:A less painful colonoscopy 2Health News:A less painful colonoscopy 3Health News:Study: Resiniferatoxin may increase sepsis-related mortality 2Health News:New study: Health reform to make health insurance affordable for nearly all families 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: